Daily administration increases the risk of methionine overload, elevated homocysteine, and gastrointestinal side effects without improving fat oxidation beyond what the liver can process
As of July 2026, retatrutide (LY3437943) remains an investigational drug in Phase 3 clinical trials (Eli Lilly's TRIUMPH program)
The drug recently showed very promising early Phase II data in MASH, a liver disease closely associated with obesity
Other Benefits of Glutathione IV Therapy Reduces inflammation: Helps with conditions like arthritis and chronic pain
In this blog post, well delve into Semaglutide, how it works, and why it could be the perfect addition to your weight loss journey
Saxenda, a GLP-1 receptor agonist licensed in the UK for obesity and overweight with comorbidities, is not officially associated with acne in its Summary of Product Characteristics or clinical trial data